Doctors Discuss Science and Risks of Ozempic Microdosing
Doctors explain the science behind using small doses of Ozempic, a GLP-1 receptor agonist, and discuss potential risks associated with microdosing this medication. The discussion covers how microdosing might affect weight loss and diabetes management, highlighting both benefits and safety concerns.
ThePrint·




